1.05671

Lithium carbonate

EMPROVE^® ESSENTIAL, Ph. Eur., BP, USP

• 別名: Lithium carbonate
• 実験式（ヒル表記法）: CLi₂O₃
• CAS番号: 554-13-2
• 分子量: 73.89
• MDL番号: MFCD00011084
• UNSPSCコード: 12352302
• EC Index Number: 209-062-5

特性

• 認証: BP; Ph. Eur.; USP
• 品質水準: 500
• 詳細: EMPROVE^® ESSENTIAL Ph Eur,BP,USP
• 製品種目: EMPROVE^® ESSENTIAL
• 形状: solid
• 有効性: 525 mg/kg LD₅₀, oral (Rat)
• pH: 10-11 (20 °C, 5 g/L in H₂O)
• mp: 720 °C
• 密度: 2.1 g/cm³ at 20 °C
• アプリケーション: pharmaceutical; solid formulation
• 保管温度: 15-25°C
• InChI: 1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
• InChI Key: XGZVUEUWXADBQD-UHFFFAOYSA-L

詳細

詳細

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge in formulation. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our EMPROVE^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

アプリケーション

Lithium carbonate Emprove^® Essential is mainly used in highly regulated pharmaceutical applications.

法的情報

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302 - H319
• 注意書き: P264 - P270 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313
• 危険有害性の分類: Acute Tox. 4 Oral - Eye Irrit. 2
• 保管分類コード: 13 - Non Combustible Solids
• WGK: WGK 1
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable